BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19593170)

  • 1. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression.
    Bauer M; Pfennig A; Linden M; Smolka MN; Neu P; Adli M
    J Clin Psychopharmacol; 2009 Aug; 29(4):327-33. PubMed ID: 19593170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm study.
    Adli M; Berghöfer A; Linden M; Helmchen H; Müller-Oerlinghausen B; Mackert A; Stamm T; Bauer M
    J Clin Psychiatry; 2002 Sep; 63(9):782-90. PubMed ID: 12363118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
    Trivedi MH; Rush AJ; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Key T; Biggs MM; Shores-Wilson K; Witte B; Suppes T; Miller AL; Altshuler KZ; Shon SP
    Arch Gen Psychiatry; 2004 Jul; 61(7):669-80. PubMed ID: 15237079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Algorithm-guided treatment versus treatment as usual for major depression.
    Yoshino A; Sawamura T; Kobayashi N; Kurauchi S; Matsumoto A; Nomura S
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):652-7. PubMed ID: 19674382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.
    Adli M; Wiethoff K; Baghai TC; Fisher R; Seemüller F; Laakmann G; Brieger P; Cordes J; Malevani J; Laux G; Hauth I; Möller HJ; Kronmüller KT; Smolka MN; Schlattmann P; Berger M; Ricken R; Stamm TJ; Heinz A; Bauer M
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):721-730. PubMed ID: 28645191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients.
    Linden M; Helmchen H; Mackert A; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1994 Jul; 27 Suppl 1():51-3. PubMed ID: 7984703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.
    Wiethoff K; Bauer M; Baghai TC; Möller HJ; Fisher R; Hollinde D; Kiermeir J; Hauth I; Laux G; Cordes J; Brieger P; Kronmüller KT; Zeiler J; Adli M
    J Clin Psychiatry; 2010 Aug; 71(8):1047-54. PubMed ID: 20673545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
    van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
    J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of a 4-step treatment algorithm for depressed inpatients.
    Birkenhäger TK; van den Broek WW; Moleman P; Bruijn JA
    J Clin Psychiatry; 2006 Aug; 67(8):1266-71. PubMed ID: 16965206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of 1014 naturalistically treated inpatients with major depressive episode.
    Seemüller F; Riedel M; Obermeier M; Bauer M; Adli M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Dichgans E; Bottländer R; Musil R; Möller HJ
    Eur Neuropsychopharmacol; 2010 May; 20(5):346-55. PubMed ID: 20097046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter gene and response to lithium augmentation in depression.
    Stamm TJ; Adli M; Kirchheiner J; Smolka MN; Kaiser R; Tremblay PB; Bauer M
    Psychiatr Genet; 2008 Apr; 18(2):92-7. PubMed ID: 18349701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.
    Schramm E; Schneider D; Zobel I; van Calker D; Dykierek P; Kech S; Härter M; Berger M
    J Affect Disord; 2008 Jul; 109(1-2):65-73. PubMed ID: 18067973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
    Tew JD; Mulsant BH; Haskett RF; Joan P; Begley AE; Sackeim HA
    Ann Clin Psychiatry; 2007; 19(1):1-4. PubMed ID: 17453654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial.
    Watanabe N; Furukawa TA; Shimodera S; Morokuma I; Katsuki F; Fujita H; Sasaki M; Kawamura C; Perlis ML
    J Clin Psychiatry; 2011 Dec; 72(12):1651-8. PubMed ID: 21457679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
    George MS; Rush AJ; Marangell LB; Sackeim HA; Brannan SK; Davis SM; Howland R; Kling MA; Moreno F; Rittberg B; Dunner D; Schwartz T; Carpenter L; Burke M; Ninan P; Goodnick P
    Biol Psychiatry; 2005 Sep; 58(5):364-73. PubMed ID: 16139582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
    J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Algorithm-guided treatment of depression reduces treatment costs--results from the randomized controlled German Algorithm Project (GAPII).
    Ricken R; Wiethoff K; Reinhold T; Schietsch K; Stamm T; Kiermeir J; Neu P; Heinz A; Bauer M; Adli M
    J Affect Disord; 2011 Nov; 134(1-3):249-56. PubMed ID: 21757237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.